122 related articles for article (PubMed ID: 12661919)
1. Cardioprotection by metformin is abolished by a nitric oxide synthase inhibitor in ischemic rabbit hearts.
Kawabata H; Ishikawa K
Hypertens Res; 2003 Jan; 26(1):107-10. PubMed ID: 12661919
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin.
Kawabata H; Ishikawa K
Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407
[TBL] [Abstract][Full Text] [Related]
3. A novel cardioprotective agent, JTV-519, is abolished by nitric oxide synthase inhibitor on myocardial metabolism in ischemia-reperfused rabbit hearts.
Kawabata H; Nakagawa K; Ishikawa K
Hypertens Res; 2002 Mar; 25(2):303-9. PubMed ID: 12047047
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac ATP-sensitive K+ channels induced by HMG CoA reductase inhibitor in ischemic rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Sep; 24(5):573-7. PubMed ID: 11675953
[TBL] [Abstract][Full Text] [Related]
6. Effects of an HMG-CoA reductase inhibitor in combination with an ACE inhibitor or angiotensin II type 1 receptor antagonist on myocardial metabolism in ischemic rabbit hearts.
Kawabata H; Nakagawa K; Ishikawa K
Hypertens Res; 2002 Mar; 25(2):203-10. PubMed ID: 12047036
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Bradamante S; Barenghi L; Piccinini F; Bertelli AA; De Jonge R; Beemster P; De Jong JW
Eur J Pharmacol; 2003 Mar; 465(1-2):115-23. PubMed ID: 12650840
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the nitric oxide metabolism overcomes the unresponsiveness of the diabetic human myocardium to protection against ischemic injury.
Barua A; Standen NB; GaliƱanes M
J Surg Res; 2011 Dec; 171(2):452-6. PubMed ID: 20869072
[TBL] [Abstract][Full Text] [Related]
9. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
Liu JC; Kang J; Shao LJ; He M
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide inhibition improved myocardial metabolism independent of tissue perfusion during ischemia but not during reperfusion.
Araki M; Tanaka M; Hasegawa K; Yokota R; Maeda T; Ishikawa M; Yabuuchi Y; Sasayama S
J Mol Cell Cardiol; 2000 Mar; 32(3):375-84. PubMed ID: 10731437
[TBL] [Abstract][Full Text] [Related]
11. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and reperfusion in the rat isolated perfused heart.
Pabla R; Curtis MJ
J Mol Cell Cardiol; 1996 Oct; 28(10):2111-21. PubMed ID: 8930806
[TBL] [Abstract][Full Text] [Related]
12. Effect of desflurane-induced preconditioning following ischemia-reperfusion on nitric oxide release in rabbits.
Tsai SK; Lin SM; Huang CH; Hung WC; Chih CL; Huang SS
Life Sci; 2004 Dec; 76(6):651-60. PubMed ID: 15567190
[TBL] [Abstract][Full Text] [Related]
13. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
14. Effect of an endothelin receptor antagonist and an angiotensin converting enzyme inhibitor on metabolism and contraction in the ischemic and reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 1999 Oct; 63(10):770-4. PubMed ID: 10553919
[TBL] [Abstract][Full Text] [Related]
15. The role of nitric oxide, K(+)(ATP) channels, and cGMP in the preconditioning response of the rabbit.
Horimoto H; Gaudette GR; Saltman AE; Krukenkamp IB
J Surg Res; 2000 Jul; 92(1):56-63. PubMed ID: 10864483
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia.
Weinbrenner C; Liu GS; Downey JM; Cohen MV
Cardiovasc Res; 1998 Jun; 38(3):676-84. PubMed ID: 9747435
[TBL] [Abstract][Full Text] [Related]
17. Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide.
Cross HR; Murphy E; Koch WJ; Steenbergen C
Cardiovasc Res; 2002 Feb; 53(3):662-71. PubMed ID: 11861037
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of Ilex paraguariensis extract: evidence for a nitric oxide-dependent mechanism.
Schinella G; Fantinelli JC; Mosca SM
Clin Nutr; 2005 Jun; 24(3):360-6. PubMed ID: 15869828
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin improves postischaemic recovery in the rat heart: role of high energy phosphates, nitric oxide, and prostacyclin.
Zhu P; Zaugg CE; Simper D; Hornstein P; Allegrini PR; Buser PT
Cardiovasc Res; 1995 May; 29(5):658-63. PubMed ID: 7606754
[TBL] [Abstract][Full Text] [Related]
20. Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
Davani S; Vergely C; Royer B; Bouhaddi M; Reyssie H; Rochette L; Kantelip JP
Cell Mol Biol (Noisy-le-grand); 2007 Jan; 52 Suppl():OL868-73. PubMed ID: 17543224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]